ArticleFrontiers in immunology2021

Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.

Casey O Lightbourn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.